Cytokinetics started at strong buy with $39 stock price target at Raymond James Jul. 10, 2020 at 7:22 a.m. ET by Tomi Kilgore Other News Press Releases Roblox downgraded, Pinterest upgraded: Wall Street’s top analyst calls Feb. 7, 2025 at 9:45 a.m. ET on TipRanks.com Cyto...
Get the latest Cytokinetics Incorporated (CYTK) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
CYTK - Stock Price ChartPeers: VRTX REGN BIIB AMGN GILD NBIX ARRY EXAS INCY FGEN | Held by: IJH VTI IWM VB VXF VBK XBI IWN MDY IBB Scroll to Statements Index RUT P/E - EPS (ttm) -5.39 Insider Own 3.77% Shs Outstand 117.89M Perf Week -13.55% Market Cap 5.05B Forward P/E ...
Cytokinetics Price Target Maintained With a $72.00/Share by Needham Dow Jones·08/10 05:14 Needham Reiterates Buy on Cytokinetics, Maintains $72 Price Target Benzinga·08/10 05:04 Cytokinetics (CYTK) Q2 Loss Wider Than Expected, Pipeline in Focus ...
A high-level overview of Cytokinetics, Incorporated (CYTK) stock. View (CYTK) real-time stock price, chart, news, analysis, analyst reviews and more.
Get Cytokinetics Inc (CYTK:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. This article is not financial advice. See Quiver Quantitative's disclaimers for more information. This article was originally published on Quiver News, read the full story. The views and opinion...
This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The stock might move higher if these key numbers top expectations in the ...
share comments recommended for you about cytk stock symbol last price % chg 1d 5d 1m 6m 1y 5y 10y market cap pe yield rev growth (yoy) short interest prev. close compare to peers more on cytk related stocks symbol last price % chg cytk cytk - - 1d 5d 1m 6m 1y 5y 10...
Currently, the analyst consensus on Amedisys is a Hold with an average price target of $101.00, which is an 8.5% upside from current levels. In a report issued on March 4, Leerink Partners also maintained a Hold rating on the stock with a $101.00 price...